Singapore greenlights clinical trials for vaccine candidate developed by Arcturus and Duke-NUS Medical School

Biopharmaceutical company Arcturus and Singapore's Duke-NUS said they will begin human dosing tests of their potential coronavirus vaccine as soon as possible.

from Health and Science https://ift.tt/3fOt4X6
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH